Dr David Simmons
MRC bodies you are a member of:
- Infection and Immunity Board
- Experimental Medicine Challenge Grants – cross board group
Main form of employment:
- Cellzome td, Chesterford Research Park, Cambridge CB10 1XL, Chief Scientific Officer
Research group/department web page/s:
Personal remuneration:
- Cellzome Ltd
Shareholdings and financial interests in companies
- Cellzome Ltd
Research income during current session [over £50k per grant]
- Collaborations with GlaxoSmithKline Immuno-inflammation therapy area on kinases and epigenetic targets
- Technology Strategy Board, Regenerative Medicine
- European Union FP7: Blueprint (haematopoietic epigenomes), Orchid (Tuberculosis drug discovery)
Major academic collaborators [national and international]
- University of Sheffield – Prof Peter Andrews, TSB Regenerative Medicine grant
- Babraham Research Institute – Martin Turner
- EU FP7 Blueprint – Haematopoietic Epigenomes – 40 partners in consortium
- EU FP7 Orchid – Tuberculosis drug discovery – main academic collaborator: Prof Gudyral Besra, University of Birmingham
Un-remunerated involvement with and membership of medical, bio-medical, pharmaceutical, healthcare provision or science or health policy/communication and similar activities/organisations
- Honorary Professor, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham
Political/pressure group associations:
- None
Family:
- None
